StockData
Baxter International Inc logo

Baxter International Inc (BAX) stock

BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/306% above fair value
$26.16+0.40 (+1.55%)

Close on Nov 18, 2026Market cap $13.53BP/E –Yield 1.99%

Baxter International operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Baxter International's operating income for the twelve months ending Sep 30, 2026 was -$221.00M. For fiscal 2025 it was -$308.00M, down 2300.0% from the year before. The highest annual figure on record is $1.77B in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$308.00M-2300.0%
FY2024Dec 31, 2024$14.00M-98.0%
FY2023Dec 31, 2023$707.00M–
FY2022Dec 31, 2022-$2.85B-310.7%
FY2021Dec 31, 2021$1.35B-16.5%
FY2020Dec 31, 2020$1.62B-8.8%
FY2019Dec 31, 2019$1.77B+11.9%
FY2018Dec 31, 2018$1.58B+23.0%
FY2017Dec 31, 2017$1.29B+72.9%
FY2016Dec 31, 2016$745.00M+65.9%
FY2015Dec 31, 2015$449.00M-31.6%
FY2014Dec 31, 2014$656.00M+32.3%
FY2013Dec 31, 2013$496.00M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$225.00M+30.8%
Q2 FY2026Jun 30, 2026$217.00M+13.6%
Q1 FY2026Mar 31, 2026$66.00M+13.8%
Q4 FY2025Dec 31, 2025-$729.00M–
Q3 FY2025Sep 30, 2025$172.00M+11.0%
Q2 FY2025Jun 30, 2025$191.00M+6.7%
Q1 FY2025Mar 31, 2025$58.00M-49.6%
Q4 FY2024Dec 31, 2024-$435.00M-243.1%
Q3 FY2024Sep 30, 2024$155.00M-13.4%
Q2 FY2024Jun 30, 2024$179.00M–
Q1 FY2024Mar 31, 2024$115.00M-10.9%
Q4 FY2023Dec 31, 2023$304.00M–
Q3 FY2023Sep 30, 2023$179.00M–
Q2 FY2023Jun 30, 2023-$17.00M-106.4%
Q1 FY2023Mar 31, 2023$129.00M-20.9%
Q4 FY2022Dec 31, 2022-$312.00M-1456.5%
Q3 FY2022Sep 30, 2022-$2.88B-661.4%
Q2 FY2022Jun 30, 2022$264.00M-37.7%
Q1 FY2022Mar 31, 2022$163.00M-58.2%
Q4 FY2021Dec 31, 2021$23.00M-94.3%
Q3 FY2021Sep 30, 2021$513.00M+9.1%
Q2 FY2021Jun 30, 2021$424.00M+28.1%
Q1 FY2021Mar 31, 2021$390.00M-4.6%
Q4 FY2020Dec 31, 2020$406.00M-24.3%
Q3 FY2020Sep 30, 2020$470.00M-6.6%
Q2 FY2020Jun 30, 2020$331.00M-5.4%
Q1 FY2020Mar 31, 2020$409.00M+6.8%
Q4 FY2019Dec 31, 2019$536.00M+37.1%
Q3 FY2019Sep 30, 2019$503.00M+31.7%
Q2 FY2019Jun 30, 2019$350.00M-7.2%
Q1 FY2019Mar 31, 2019$383.00M-11.8%
Q4 FY2018Dec 31, 2018$391.00M+35.8%
Q3 FY2018Sep 30, 2018$382.00M+27.3%
Q2 FY2018Jun 30, 2018$377.00M+8.6%
Q1 FY2018Mar 31, 2018$434.00M+22.9%
Q4 FY2017Dec 31, 2017$288.00M-5.0%
Q3 FY2017Sep 30, 2017$300.00M–
Q2 FY2017Jun 30, 2017$347.00M–
Q1 FY2017Mar 31, 2017$353.00M–
Q4 FY2016Dec 31, 2016$303.00M–

More Baxter International figures

See a number that looks wrong?